AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 3.090
+0.020 (0.65%)
At close: Feb 13, 2026
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 3.77 billion as of February 13, 2026. Its market cap has decreased by -38.91% in one year.
Market Cap
3.77B
Enterprise Value
5.54B
Revenue
1.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
3.09
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 3.77B, a decrease of -81.32%. That is a compound annual growth rate of -39.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 3.77B | -4.36% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laekna | 5.12B |
| Viva Biotech Holdings | 4.98B |
| Shandong Boan Biotechnology | 4.83B |
| Jacobio Pharmaceuticals Group | 4.79B |
| TYK Medicines | 4.78B |
| Beijing Luzhu Biotechnology | 4.56B |
| Qyuns Therapeutics | 4.45B |
| Medtide | 3.43B |